GRO BIOSCIENCES
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders, and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.
GRO BIOSCIENCES
Industry:
Biotechnology Health Diagnostics Medical Device Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.grobio.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 903 8359
Total Funding:
32.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
Alumni Ventures
Alumni Ventures investment in Series A - GRO Biosciences
Digitalis Ventures
Digitalis Ventures investment in Series A - GRO Biosciences
Redmile Group
Redmile Group investment in Series A - GRO Biosciences
Innovation Endeavors
Innovation Endeavors investment in Series A - GRO Biosciences
Leaps by Bayer
Leaps by Bayer investment in Series A - GRO Biosciences
National Science Foundation
National Science Foundation investment in Grant - GRO Biosciences
Innovation Endeavors
Innovation Endeavors investment in Seed Round - GRO Biosciences
Rising Tide
Rising Tide investment in Seed Round - GRO Biosciences
OS Fund
OS Fund investment in Seed Round - GRO Biosciences
Digitalis Ventures
Digitalis Ventures investment in Seed Round - GRO Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-16 | GRO Biosciences Strengthens Management Team With Appointment of Veteran Biotechnology Executive, Edward Stewart as Chief Business Officer |
Official Site Inspections
http://www.grobio.com Semrush global rank: 1.51 M Semrush visits lastest month: 17.75 K
- Host name: 226.11.145.34.bc.googleusercontent.com
- IP address: 34.145.11.226
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GRO Biosciences"
GRO Biosciences – Delivering on the Promise of …
Oct 8, 2024 GRObio’s groundbreaking science redefines protein therapeutics with an expanded amino acid alphabet. We have developed the only synthetic biology platform that grants access to the full universe of non-standard amino …See details»
GRO Biosciences - Crunchbase Company Profile
GRO Biosciences closed a $60 million Series B financing round co-led by Atlas Venture and Access Biotechnology. The funds will be used to advance their protein therapeutics technology and take a gout treatment rival to Krystexxa …See details»
Careers – GRO Biosciences
GRObio has an inclusive work environment that celebrates diverse perspectives, backgrounds, and approaches to science and business. ... "GRO has been my favorite company to work at …See details»
Grobo - Crunchbase Company Profile & Funding
Organization. Grobo . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Grobo uses scientific methods and data-driven …See details»
Leaps by Bayer
GRObio is advancing its first two families of NSAA platform chemistries to build its product pipeline. DuraLogicâ„¢ chemistries focus on therapeutic stability and dosing schedule, while …See details»
grobio.io
GroBio is dedicated to fine-tuning and enhancing the commercial strategies of our clients. We believe that an effective commercial strategy is the backbone of success in the life sciences …See details»
GRO Biosciences Expands Executive Team with Appointment of …
BOSTON, March 18, 2024--GRO Biosciences Inc. ("GRObio"), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the …See details»
GRO Biosciences (USA) Funding: $92.3M - medicalstartups.org
Nov 20, 2024 Website: https://www.grobio.com GRO Biosciences is a biotechnology company that expands the amino acid alphabet to overcome the limitations of protein therapeutics. …See details»
Core Values – GRO Biosciences
The GRObio team developed and refined our core values to reflect our diverse and inclusive team and our passion to improve health outcomes for patients.See details»
GRO Biosciences - BIO CEO & Investor Conference | BIO
Feb 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... GRO …See details»
GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas …
BOSTON, July 19, 2024--GRO Biosciences Inc. ("GRObio"), a biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein …See details»
GRObio Appoints Tracey Lodie, PhD, as Chief Development Officer
Mar 22, 2024 With a proven track record in immunology and biopharmaceutical development, Dr. Lodie’s expertise is poised to accelerate GRObio’s journey from research to real-world …See details»
Synbio startup GRObio gets $25M to work with new building …
Nov 3, 2021 Dan Mandell, GRObio’s co-founder and CEO, was a research fellow in genetics at Harvard, where he worked with Church on computational design of new proteins whose folding …See details»
Partnerships – GRO Biosciences
Accelerate the expansion and development of GRObio’s current pipeline of programs; Extend ProGlyâ„¢ and other NSAA chemistries into new disease areas and therapeutic modalities; …See details»
Grobo - Updates, News, Events, Signals & Triggers - Crunchbase
SynBioBeta — GRObio Secures $60.3 Million in Series B Financing to Advance Protein Therapeutics News • Jul 19, 2024 MedCity News — Aiming to Top Amgen in Gout, Startup …See details»
GRObio’s team is comprised of world-renowned pioneers with
GRObio’s team is comprised of world-renowned pioneers with decades-long careers of innovation in protein engineering and #pharmaceutical development. Our...See details»
GRO Biosciences Announces Appointment of Bruce Beutel, PhD to …
Dec 9, 2021 GRObio appointed Bruce Beutel, PhD to its Board of Directors. Dr. Beutel is an expert in novel therapeutics and platform research, business development, and company …See details»
GRObio Company Overview on Vimeo
This is "GRObio Company Overview" by Four a Minute Productions on Vimeo, the home for high quality videos and the people who love them. Solutions . Video marketing. Power your …See details»
News – GRO Biosciences
Jul 19, 2024 Biotech TV host Brad Loncar visited GRObio’s office in Cambridge and had a discussion with GRObio CEO Dan Mandell, PhD about the Company’s recent Series B …See details»